GLICLAZID MYLAN

30MG TBL MRL 120

SÚKL code 0147116
Name of the product GLICLAZID MYLAN
_MA_MEDICATION_DETAIL_INFO_MED_NAME i GLICLAZID MYLAN
Supplement 30MG TBL MRL 120
Strenght 30MG
Pharmaceutical form Modified-release tablet
Package 120
Route Oral use
Language of the pack Czech
Wrap type Blister
Legal status na lékařský předpis
Active substance GLICLAZIDE (GLICLAZIDUM)
ATC group A10BB09
ATC group name GLIKLAZID

Marketing authorisation information

Registration Number 18/ 035/10-C
Type of MA A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 28. 02. 2019
MA Holder Generics [UK] Limited, Potters Bar
MA Holder country VELKÁ BRITÁNIE
Actual MA holder Mylan Ireland Limited, Dublin
Actual MA holder country IRSKO

Back to list